- Home
- CELZ vs DSS Comparison
CELZ vs DSS Comparison
Compare CELZ & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- DSS
- Stock Information
- Founded
- CELZ 1998
- DSS 1984
- Country
- CELZ United States
- DSS United States
- Employees
- CELZ N/A
- DSS N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- DSS Containers/Packaging
- Sector
- CELZ Health Care
- DSS Consumer Discretionary
- Exchange
- CELZ Nasdaq
- DSS Nasdaq
- Market Cap
- CELZ 7.4M
- DSS 7.7M
- IPO Year
- CELZ N/A
- DSS N/A
- Fundamental
- Price
- CELZ $3.12
- DSS $0.84
- Analyst Decision
- CELZ
- DSS
- Analyst Count
- CELZ 0
- DSS 0
- Target Price
- CELZ N/A
- DSS N/A
- AVG Volume (30 Days)
- CELZ 158.4K
- DSS 61.0K
- Earning Date
- CELZ 08-08-2025
- DSS 08-26-2025
- Dividend Yield
- CELZ N/A
- DSS N/A
- EPS Growth
- CELZ N/A
- DSS N/A
- EPS
- CELZ N/A
- DSS N/A
- Revenue
- CELZ $6,000.00
- DSS $21,252,000.00
- Revenue This Year
- CELZ N/A
- DSS N/A
- Revenue Next Year
- CELZ N/A
- DSS N/A
- P/E Ratio
- CELZ N/A
- DSS N/A
- Revenue Growth
- CELZ N/A
- DSS 10.24
- 52 Week Low
- CELZ $1.69
- DSS $0.72
- 52 Week High
- CELZ $6.90
- DSS $1.50
- Technical
- Relative Strength Index (RSI)
- CELZ 54.15
- DSS 37.33
- Support Level
- CELZ $2.75
- DSS $0.80
- Resistance Level
- CELZ $3.36
- DSS $0.87
- Average True Range (ATR)
- CELZ 0.34
- DSS 0.07
- MACD
- CELZ -0.00
- DSS -0.03
- Stochastic Oscillator
- CELZ 37.59
- DSS 8.97
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About DSS DSS Inc.
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.